Status | Study |
Recruiting |
Study Name: Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus Condition: Cutaneous Lupus Erythematosus Date: 2012-01-10 |
Terminated |
Study Name: Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus Condition: Cutaneous Lupus Erythematosus Date: 2011-12-21 Interventions: Dietary Supplement: vitamin D The investigators will carry out a two-armed prospective pilot study of th |
Terminated |
Study Name: A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus Condition: Cutaneous Lupus Erythematosus Date: 2011-11-09 Interventions: Drug: PD-0360324 Subjects will |
Terminated |
Study Name: Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus Condition: Lupus Erythematosus, Cutaneous Date: 2011-08-01 Interventions: Drug: Alitretinoin 1 capsule Alitretinoin 30 mg per day; optional reduction to 10 mg per day in case una |
Terminated |
Study Name: Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus Condition: Cutaneous Lupus Lupus Date: 2011-06-23 Interventions: Drug: AMG 557 AMG 557 (210 mg) |
Completed |
Study Name: Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus Condition: Lupus Erythematosus, Cutaneous Date: 2011-04-29 Interventions: Drug: Fumaric acid esters Starting from 1 tablet Fumaderm® initial per day, with titration up to 6 |
Completed |
Study Name: Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus Condition: Subacute Cutaneous Lupus Erythematosus Date: 2011-02-10 Interventions: Drug: KRP203 - 1.2mg Drug: Placebo to KRP2 |
Completed |
Study Name: To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus Condition: Cutaneous Lupus Erythematosus Date: 2010-10-18 Interventions: Drug: CC-11050 Cohort 1: 50 mi |
Completed |
Study Name: Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) Condition: Cutaneous Lupus Erythematosus Date: 2010-05-24 Interventions: Other: UV A and B irradiation UV irradiation |
Completed |
Study Name: Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) Condition: Cutaneous Lupus Erythematosus (CLE) Date: 2008-03-04 Interventions: Drug: lenalidomide (Revlimid®) The drug will be administered in oral form. The dosage of lenalidomi |